Benzodiazepine consumption in Brazil: considerations regarding a population-specific scenario

Dokkedal-Silva, Vinícius; Galduróz, José C.F.; Tufik, Sergio; Andersen, Monica L.

Dokkedal-Silva, Vinícius; Galduróz, José C.F.; Tufik, Sergio; Andersen, Monica L..

Dokkedal-Silva, Vinícius; Universidade Federal de São Paulo. Departamento de Psicobiologia. São Paulo. BR
Galduróz, José C.F.; Universidade Federal de São Paulo. Departamento de Psicobiologia. São Paulo. BR
Tufik, Sergio; Universidade Federal de São Paulo. Departamento de Psicobiologia. São Paulo. BR
Andersen, Monica L.; Universidade Federal de São Paulo. Departamento de Psicobiologia. São Paulo. BR

Braz. J. Psychiatry (São Paulo, 1999, Impr.) ; 42(3): 332-332, May-June 2020.

Article in English | LILACS | ID: biblio-1132082

Subject(s)

Humans; Anti-Anxiety Agents/therapeutic use; Benzodiazepines/therapeutic use; Nonprescription Drugs/therapeutic use; Inappropriate Prescribing; Drug Prescriptions; Anti-Anxiety Agents/adverse effects; Brazil; Nonprescription Drugs/adverse effects

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Anti-Anxiety Agents / Benzodiazepines / Nonprescription Drugs / Inappropriate Prescribing Limits: Humans Country/Region as subject: South America / Brazil Language: English Journal: Braz. J. Psychiatry (São Paulo, 1999, Impr.) Journal subject: Psychiatry Year: 2020 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade Federal de São Paulo/BR

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google